✦ LIBER ✦

Canada wins biotech boost of cancer vaccine project

✍ Scribed by Spurgeon, David

Book ID: 109802309
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 148 KB
Volume: 388
Category: Article
ISSN: 0028-0836
DOI: 10.1038/40707

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The HPV vaccine impact monitoring projec

The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions

✍ Susan Hariri; Elizabeth R. Unger; Suzanne E. Powell; Heidi M. Bauer; Nancy M. Be 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 173 KB

Enhanced immunogenicity and antitumour e

Enhanced immunogenicity and antitumour effects with heterologous prime-boost regime using vaccines based on MG7-Ag mimotope of gastric cancer

✍ T. Lin; S. Liang; F. Meng; Q. Han; C. Guo; L. Sun; Y. Chen; Z. Liu; Z. Yu; H. Xi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

MHC II lung cancer vaccines prime and bo

MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells

✍ Minu K. Srivastava; Jacobus J. Bosch; Ashley L. Wilson; Martin J. Edelman; Suzan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 923 KB

## Abstract Nonsmall cell lung cancer (NSCLC) is the major cause of lung cancer‐related deaths in the United States. We are developing cell‐based vaccines as a new approach for the treatment of NSCLC. NSCLC is broadly divided into 3 histologic subtypes: adenocarcinoma, squamous cell carcinoma and l

Addition of adenoviral vector targeting

Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells

✍ Akbulut, H; Tang, Y; Akbulut, K G; Maynard, J; Deisseroth, A 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 409 KB